Medicines Patent Pool has joined forces with over 30 generic manufacturers to help ensure access to anti-COVID-19 medicines for all.

What are the key decisions that need to be made for cell therapy supply chains?

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

We find out how technology is enabling remote inspections in the pharma industry.

With the FDA still behind on inspections, manufacturers need to uncover their own blindspots.

How pharmaceutical therapeutics are expanding into a whole new galaxy of options.

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.

That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?

Our eBook features mRNA vs malaria, vaccines, top tips for mRNA sequencing, and more

How can smaller biopharma companies overcome the scale up and production complexities for microbial biomanufacturing?